Lee Anderson

4.7k total citations · 1 hit paper
32 papers, 3.2k citations indexed

About

Lee Anderson is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lee Anderson has authored 32 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Genetics. Recurrent topics in Lee Anderson's work include BRCA gene mutations in cancer (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cancer-related Molecular Pathways (4 papers). Lee Anderson is often cited by papers focused on BRCA gene mutations in cancer (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cancer-related Molecular Pathways (4 papers). Lee Anderson collaborates with scholars based in United States, Switzerland and United Kingdom. Lee Anderson's co-authors include Mary‐Claire King, Jeff Hall, Ming K. Lee, Bing Huey, Beth Newman, Dennis J. Slamon, Charles Ginther, Marlena S. Fejzo, Judy Dering and Beth Y. Karlan and has published in prestigious journals such as Science, Cancer Research and Oncogene.

In The Last Decade

Lee Anderson

32 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21

1990 1.8k citations Ming K. Lee, Lee Anderson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lee Anderson United States	23	1.7k	1.6k	831	766	535	32	3.2k
B. A. J. Ponder United Kingdom	30	1.4k 0.8×	1.6k 1.0×	994 1.2×	733 1.0×	775 1.4×	54	3.7k
B A Ponder United Kingdom	25	1.3k 0.8×	1.1k 0.7×	745 0.9×	483 0.6×	444 0.8×	39	2.7k
Michel Longy France	35	940 0.6×	2.4k 1.5×	1.3k 1.6×	864 1.1×	1.0k 1.9×	93	4.0k
Patrícia Ashton‐Prolla Brazil	30	862 0.5×	1.2k 0.8×	1.1k 1.3×	712 0.9×	353 0.7×	158	2.9k
Cliff Meldrum Australia	24	778 0.5×	1.0k 0.7×	1.1k 1.3×	789 1.0×	619 1.2×	57	2.6k
Patricia N. Tonin Canada	37	1.7k 1.0×	2.7k 1.7×	1.2k 1.4×	1.0k 1.4×	732 1.4×	127	4.5k
C. Sue Richards United States	20	913 0.5×	934 0.6×	434 0.5×	386 0.5×	274 0.5×	41	2.3k
Siranoush Manoukian Italy	26	1.3k 0.8×	992 0.6×	637 0.8×	798 1.0×	435 0.8×	81	2.6k
Sigurður Ingvarsson Iceland	29	1.2k 0.7×	2.0k 1.3×	725 0.9×	905 1.2×	574 1.1×	95	3.1k
Shirley V. Hodgson United Kingdom	29	1.2k 0.7×	1.7k 1.1×	1.2k 1.4×	1.2k 1.5×	1.6k 2.9×	59	3.9k

Countries citing papers authored by Lee Anderson

Since Specialization

Citations

This map shows the geographic impact of Lee Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Anderson more than expected).

Fields of papers citing papers by Lee Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Anderson. The network helps show where Lee Anderson may publish in the future.

Co-authorship network of co-authors of Lee Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Anderson. A scholar is included among the top collaborators of Lee Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Anderson. Lee Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fejzo, Marlena S., Hsiao‐Wang Chen, Lee Anderson, et al.. (2020). Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition. Gynecologic Oncology. 160(2). 539–546. 16 indexed citations

Fejzo, Marlena S., Lee Anderson, Hsiao‐Wang Chen, et al.. (2017). Proteasome ubiquitin receptor PSMD4 is an amplification target in breast cancer and may predict sensitivity to PARPi. Genes Chromosomes and Cancer. 56(8). 589–597. 27 indexed citations

Hurvitz, Sara A., Ondrej Kalous, Dylan Conklin, et al.. (2015). In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response. Breast Cancer Research and Treatment. 149(3). 669–680. 46 indexed citations

Hamidi, Habib, Ming Lu, Lee Anderson, et al.. (2014). KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition. British Journal of Cancer. 111(9). 1788–1801. 42 indexed citations

Kalous, Ondrej, Dylan Conklin, Amrita Desai, et al.. (2013). AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53. Breast Cancer Research and Treatment. 141(3). 397–408. 22 indexed citations

Karlan, Beth Y., Judy Dering, Christine Walsh, et al.. (2013). POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer. Gynecologic Oncology. 132(2). 334–342. 75 indexed citations

Desai, Amrita, Erika von Euw, Dylan Conklin, et al.. (2013). PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.. PubMed. 33(8). 2997–3004. 88 indexed citations

Finn, Richard S., Danyun Zhao, Lee Anderson, et al.. (2012). Abstract 3858: Gains in FGF19 are predictive of response to the fibroblast growth factor receptor (FGFR) small molecule tyrosine kinase inhibitor BGJ 398 in vitro. Cancer Research. 72(8_Supplement). 3858–3858. 13 indexed citations

Bebek, Gürkan, Charles Ginther, Kristen L. Lozada, et al.. (2012). FOXA1 represses the molecular phenotype of basal breast cancer cells. Oncogene. 32(5). 554–563. 116 indexed citations

10.

Kalous, Ondrej, Dylan Conklin, Amrita Desai, et al.. (2012). Dacomitinib (PF-00299804), an Irreversible Pan-HER Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib. Molecular Cancer Therapeutics. 11(9). 1978–1987. 58 indexed citations

11.

Fejzo, Marlena S., Judy Dering, Lee Anderson, et al.. (2011). Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK. Genes Chromosomes and Cancer. 50(6). 434–441. 14 indexed citations

12.

Tap, William D., Fritz C. Eilber, Charles Ginther, et al.. (2010). Evaluation of well‐differentiated/de‐differentiated liposarcomas by high‐resolution oligonucleotide array‐based comparative genomic hybridization. Genes Chromosomes and Cancer. 50(2). 95–112. 83 indexed citations

13.

Zhu, Min, Marlena S. Fejzo, Lee Anderson, et al.. (2010). Periostin promotes ovarian cancer angiogenesis and metastasis. Gynecologic Oncology. 119(2). 337–344. 87 indexed citations

14.

Fejzo, Marlena S., Judy Dering, Lee Anderson, et al.. (2008). Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Genes Chromosomes and Cancer. 47(10). 873–883. 40 indexed citations

15.

Friedman, Lori S., Elizabeth Ostermeyer, Eric D. Lynch, et al.. (1995). 22 genes from chromosome 17q21: cloning, sequencing, and characterization of mutations in breast cancer families and tumors. Genomics. 25(1). 256–263. 41 indexed citations

16.

Crichton, P. B., Lee Anderson, G. Phillips, Peter Davey, & D.I. Rowley. (1995). Subspecies discrimination of staphylococci from revision arthroplasties by ribotyping. Journal of Hospital Infection. 30(2). 139–147. 14 indexed citations

17.

Anderson, Lee, Lori S. Friedman, Sherri Osborne‐Lawrence, et al.. (1993). High-Density Genetic Map of the BRCA1 Region of Chromosome 17q12-q21. Genomics. 17(3). 618–623. 76 indexed citations

18.

Alich, Agnes, et al.. (1992). Gastric mucosal damage due to aspirin and copper aspirinate assessed by gastric mucosal potential difference changes. Journal of Pharmacological and Toxicological Methods. 27(4). 245–250. 3 indexed citations

19.

Wittmers, Lorentz E., et al.. (1990). Intragastric inulin as a measure of mucosal damage caused by aspirin. Journal of Pharmacological Methods. 24(3). 229–239. 1 indexed citations

20.

Hwang, Peter K., et al.. (1987). Intron/exon structure of the human gene for the muscle isozyme of glycogen phosphorylase. Proteins Structure Function and Bioinformatics. 2(3). 177–187. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact